Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002
Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002
Management of Acute Optic Neuritis
Lancet 360:1953-1962, Hickman,S.J.,et al, 2002
Immunization and MS
Neurol 59:1837-1843, Rutschmann,O.T.,et al, 2002
Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002
Thymoma in Patients with MG
Neurol 59:1844-1850, Evoli,A.,et al, 2002
Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002
Clinicopath Conf., Takayasu's Arteritis
NEJM 347:2057-2065, Case 39-2002, 2002
Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002
Acute Disseminated Encephalomyelitis
Neurol 59:1224-1231, Tenembaum,S.,et al, 2002
High-Dose Thiopental in the Treatment of Refractory Status Epilepticus in Intensive Care Unit
Neurol 59:1249-1251, Parviainen,I.,et al, 2002
Intakes of Vitamins E and C, Carotenoids, Vitamin Supplements, and PD Risk
Neurol 59:1161-1169, Zhang,S.M.,et al, 2002
T2-weighted MRI Differentiates Multiple System Atrophy from Parkinson's Disease
Neurol 59;1265-1267, Kraft,E.,et al, 2002
Goosebumps
Lancet 360:690, Cutts,J.,et al, 2002
Assessment of Normal-Appearing White and Gray Matter in Patients with Primary Progressive Multiple Sclerosis
Arch Neurol 59:1406-1412, Rovaris,M.,et al, 2002
CADASIL Mimicking Primary Angiitis of the Central Nervous System
Arch Neurol 59:1480-1483, Engelter,S.T.,et al, 2002
Brain Abscess and Necrotic Brain Tumor:Discrimination with Proton MR Spectroscopy and Diffusion-Weighted Imaging
AJNR 23:1369-1377, Lai,P.H.,et al, 2002
Polymyalgia Rheumatica and Giant-Cell Arteritis
NEJM 347:261-271, Salvarani,C.,et al, 2002
Long-term Prognosis After Recovery from Primary Intracerebral Hemorrhage
Neurol 59:205-209, Vermeer,S.E.,et al, 2002
Intravascular Lymphomatosis Presenting as Posterior Leukoencephalopathy
Arch Neurol 59:640-641, Moussouttas,M., 2002
Radiotherapy-induced Cerebral Abnormalities in Patients with Low-grade Glioma
Neurol 59:121-123,8, Postma,T.J.,et al, 2002
Worsening of Multifocal Motor Neuropathy During Pregnancy
Neurol 59:139-141, Chaudhry,V.,et al, 2002
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002
Main Trunk Tibial Neuropathies
Neurol 59:1082-1084, Drees,C.,et al, 2002
Features of Medication Overuse Headache Following Overuse of Different Acute Headache Drugs
Neurol 59:1011-1014,972, Limmroth,V.,et al, 2002
Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002
MRI Predictors of Early Conversion to Clinically Definite MS in the CHAMPS Placebo Group
Neurol 59:998-1005, CHAMPS Study Group, 2002
Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002
Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002
Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002
Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002
Clinicopath Conf., Prolactinoma
NEJM 347:1604-1611, Case 35-2002, 2002
Long-Term Durability of Carotid Endarterectomy for Symptomatic Stenosis and Risk Factors for Late Postoperative Stroke
Stroke 33;2658-2663, Cunningham,E.J.,et al, 2002
Effect of Radiotherapy and Other Treatment-Related Factors on Mid-Term to Long-Term Cognitive Sequelae in Low-Grade Gliomas: A Comparative Study
Lancet 360:1361-1368, Klein,M.,et al, 2002
A Blinding Combination
Lancet 360:1220, Matthews,B.N.,et al, 2002
Prospective Assessment of Risk Factors for Recurrent Stroke During Childhood--A 5-year Follow-up Study
Lancet 360:1540-1545,1526, Strater,R.,et al, 2002
Tourette's Syndrome
Lancet 360:1577-1586, Leckman,J.F., 2002
Primary CNS Lymphoma
Neurol 59:1557-1562, Lai,R.,et al, 2002
Posterior Circulation Stroke in Childhood
Neurol 59:1552-1556, Ganesan,V.,et al, 2002
A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002
Rectal Diazepam Gel for Treatment of Acute Repetitive Seizures in Adults
Arch Neurol 59:1915-1920, Cereghino,J.J.,et al, 2002
Outcomes of 32 Hemispherectomies for Sturge-Weber Worldwide
Neurol 59:1735-1738, Kossoff,E.H.,et al, 2002
Treatment of Spinal Epidural Metastasis Improves Patient Survival and Functional State
Neurol 58:1360-1366, Zaidat,O.O &Ruff,R.L., 2002
Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002
Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002
Gluten Sensitivity as a Neurological Illness
JNNP 72:560-563, Hadjivassiliou,M.,et al, 2002
Patients with Multiple Sclerosis and Risk of Type 1 Diabetes Mellitus in Sardinia,Italy: A Cohort Study
Lancet 359:1461-1465,1450, Marrosu,M.G.,et al, 2002
Paraneoplastic Chorea Associated with CRMP-5 Neuronal Antibody and Lung Carcinoma
Ann Neurol 51:625-630, Vernino,S.,et al, 2002